Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ben Killingley

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Drugs of Today (Barcelona, Spain : 1998)|August 31, 2007
The first once-daily single-tablet regimen for the treatment of HIV-infected patientsBen Killingley, Anton Pozniak
Influenza and Other Respiratory Viruses|September 17, 2013
Routes of influenza transmissionBen Killingley, Jonathan Nguyen-Van-Tam
The Journal of Infection|January 13, 2006
Pneumocystis pneumonia revisited: delayed diagnosis in an HIV infected individual with high blood and low lung CD4 T cell countsBen Killingley, Ronan Breen, Marc Lipman, et al.
BMJ Case Reports|May 6, 2017
<i>Pasteurella multocida</i> meningoencephalitis in an immunocompetent adult with multiple cat scratchesDavid Alistair Clarke, Angela Mcbride, Michael Kelsey, et al.
The Lancet. Infectious Diseases|July 30, 2011
Potential role of human challenge studies for investigation of influenza transmissionBen Killingley, Joanne Enstone, Robert Booy, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 17, 2018
The Effect of Influenza Virus on the Human Oropharyngeal MicrobiomeElisa Ramos-Sevillano, William G Wade, Alex Mann, et al.
Eclinicalmedicine|October 4, 2024
Changes in memory and cognition during the SARS-CoV-2 human challenge studyWilliam Trender, Peter J Hellyer, Ben Killingley, et al.
Influenza and Other Respiratory Viruses|July 25, 2020
Influenza A (H3) illness and viral aerosol shedding from symptomatic naturally infected and experimentally infected casesPaul Jacob Bueno de Mesquita, Jonathan Nguyen-Van-Tam, Ben Killingley, et al.
The Lancet. Microbe|June 12, 2023
Viral emissions into the air and environment after SARS-CoV-2 human challenge: a phase 1, open label, first-in-human studyJie Zhou, Anika Singanayagam, Niluka Goonawardane, et al.
The Journal of Infectious Diseases|December 2, 2011
Use of a human influenza challenge model to assess person-to-person transmission: proof-of-concept studyBen Killingley, Joanne E Enstone, Jane Greatorex, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Drugs of Today (Barcelona, Spain : 1998)|August 31, 2007
The first once-daily single-tablet regimen for the treatment of HIV-infected patientsBen Killingley, Anton Pozniak
Influenza and Other Respiratory Viruses|September 17, 2013
Routes of influenza transmissionBen Killingley, Jonathan Nguyen-Van-Tam
The Journal of Infection|January 13, 2006
Pneumocystis pneumonia revisited: delayed diagnosis in an HIV infected individual with high blood and low lung CD4 T cell countsBen Killingley, Ronan Breen, Marc Lipman, et al.
BMJ Case Reports|May 6, 2017
<i>Pasteurella multocida</i> meningoencephalitis in an immunocompetent adult with multiple cat scratchesDavid Alistair Clarke, Angela Mcbride, Michael Kelsey, et al.
The Lancet. Infectious Diseases|July 30, 2011
Potential role of human challenge studies for investigation of influenza transmissionBen Killingley, Joanne Enstone, Robert Booy, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 17, 2018
The Effect of Influenza Virus on the Human Oropharyngeal MicrobiomeElisa Ramos-Sevillano, William G Wade, Alex Mann, et al.
Eclinicalmedicine|October 4, 2024
Changes in memory and cognition during the SARS-CoV-2 human challenge studyWilliam Trender, Peter J Hellyer, Ben Killingley, et al.
Influenza and Other Respiratory Viruses|July 25, 2020
Influenza A (H3) illness and viral aerosol shedding from symptomatic naturally infected and experimentally infected casesPaul Jacob Bueno de Mesquita, Jonathan Nguyen-Van-Tam, Ben Killingley, et al.
The Lancet. Microbe|June 12, 2023
Viral emissions into the air and environment after SARS-CoV-2 human challenge: a phase 1, open label, first-in-human studyJie Zhou, Anika Singanayagam, Niluka Goonawardane, et al.
The Journal of Infectious Diseases|December 2, 2011
Use of a human influenza challenge model to assess person-to-person transmission: proof-of-concept studyBen Killingley, Joanne E Enstone, Jane Greatorex, et al.
Pageof 2